chr13-85794285-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032229.3(SLITRK6):āc.2224C>Gā(p.Gln742Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000688 in 1,613,304 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_032229.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151892Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 249098Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135140
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461294Hom.: 2 Cov.: 30 AF XY: 0.0000839 AC XY: 61AN XY: 726952
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152010Hom.: 1 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74310
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 12, 2022 | This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 742 of the SLITRK6 protein (p.Gln742Glu). This variant is present in population databases (rs759478977, gnomAD 0.05%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with SLITRK6-related conditions. ClinVar contains an entry for this variant (Variation ID: 1353050). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 19, 2024 | The c.2224C>G (p.Q742E) alteration is located in exon 2 (coding exon 1) of the SLITRK6 gene. This alteration results from a C to G substitution at nucleotide position 2224, causing the glutamine (Q) at amino acid position 742 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at